Sign in

CIK 0001095981 · Non-accelerated filer<br>Smaller reporting company

CERENOME, INC.

Sign in to watch
Ticker
CNSY
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
330827593
Phone
737.255.7194
Business address
6420 LEVIT GREEN BOULEVARD, SUITE 310, HOUSTON, TX, 77021
Former names
PLUS THERAPEUTICS, INC., CYTORI THERAPEUTICS, INC., MACROPORE INC
  1. 4 Open-market buy Director bought 12,000 shares at an average $2.34 ($28,139)
  2. 4 Open-market buy Director bought 10,000 shares at an average $2.49 ($24,880)
  3. 4 Open-market buy Director bought 14,400 shares at an average $2.68 ($38,586)
  4. 4 Open-market buy Director bought 1,600 shares at $2.70 ($4,320)
  5. 4 Open-market buy Director bought 4,000 shares at $2.66 ($10,640)
  6. 10-Q Report Quarterly Report
  7. 8-K Event Results of operations
  8. 8-K Event Material agreement · New debt or obligation · Unregistered share sale
  9. 4 Open-market buy Director bought 5,000 shares at an average $3.20 ($15,992)
  10. 4 Open-market buy Director bought 7,500 shares at an average $3.17 ($23,805)
  11. 4 Open-market buy Director bought 6,000 shares at an average $3.15 ($18,890)
  12. 4 Open-market buy Director bought 3,000 shares at $3.15 ($9,450)
  13. 4 Open-market buy Director bought 3,050 shares at an average $3.25 ($9,921)
  14. 4 Open-market buy Director bought 148 shares at $2.95 ($437)
  15. 8-K Event Shareholder vote results
  16. 4 Open-market buy Director bought 10,000 shares at an average $3.09 ($30,874)
  17. 4 Open-market buy Director bought 7,500 shares at $3.08 ($23,082)
  18. 4 Open-market buy President bought 2,500 shares at an average $3.19 ($7,967)
  19. 4 Open-market buy Director bought 2,000 shares at an average $3.09 ($6,188)
  20. 4 Open-market buy Chief Financial Officer bought 6,500 shares at an average $3.12 ($20,290)

Page 49 of 74 · 1,465 filings